Vaccine Potential of Mycobacterial Antigens against Asthma

Med Princ Pract. 2020;29(5):404-411. doi: 10.1159/000508719. Epub 2020 May 18.

Abstract

Asthma is a cause of substantial burden of disease in the world, including both premature deaths and reduced quality of life. A leading hypothesis to explain the worldwide increase of asthma is the "hygiene hypothesis," which suggests that the increase in the prevalence of asthma is due to the reduction in exposure to infections/microbial antigens. In allergic asthma, the most common type of asthma, antigen-specific T helper (Th)2 and Th17 cells and their cytokines are primary mediators of the pathological consequences. In contrast, Th1 and T regulatory (Treg) cells and their cytokines play a protective role. This article aims to review the information on the effect of mycobacteria and their antigens in modulating Th2/Th17 responses towards Th1/Treg responses and protection against asthma in humans and animal models.

Keywords: Asthma; Mycobacteria; Mycobacterial antigens.

Publication types

  • Review

MeSH terms

  • Animals
  • Antigens, Bacterial
  • Asthma / immunology*
  • Asthma / prevention & control*
  • BCG Vaccine / administration & dosage
  • BCG Vaccine / immunology
  • Bacterial Vaccines / administration & dosage*
  • Bacterial Vaccines / immunology*
  • Cytokines / metabolism
  • Humans
  • Inflammation Mediators / metabolism
  • Mycobacterium / immunology*
  • T-Lymphocytes, Helper-Inducer / metabolism
  • T-Lymphocytes, Regulatory / metabolism

Substances

  • Antigens, Bacterial
  • BCG Vaccine
  • Bacterial Vaccines
  • Cytokines
  • Inflammation Mediators